17 abr 2018 año - FDA is hosting a public meeting on Patient- Focused Drug Development for Opioid Use Disorder (OUD), in collaboration with National Institute of Drug Abuse (NIDA). In addition to NIDA, FDA is also working closely with patient advocacy and community organizations to encourage participation from individuals with OUD. This meeting aligns with FDA’s ongoing work aimed at reducing the impact of opioid abuse and addiction.
Añadido al timeline:
fecha:
17 abr 2018 año
Ahora mismo
~ 7 years and 6 months ago